NCT07210515

Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)

RecruitingPHASE3INTERVENTIONAL

Trial Details

Start: 2026-04-14Est. Completion: 2027-12

Enrollment target: 270 participants

Locations

Ambros Clinical Trial Site, Phoenix, Arizona, United States
Ambros Clinical Trial Site, Tucson, Arizona, United States
Ambros Clinical Trial Site, Little Rock, Arkansas, United States
Ambros Clinical Trial Site, La Jolla, California, United States
Ambros Clinical Trial Site, Napa, California, United States
Ambros Clinical Trial Site, Pasadena, California, United States
Ambros Clinical Trial Site, Tustin, California, United States
Ambros Clinical Trial Site, Washington D.C., District of Columbia, United States
Ambros Clinical Trial Site, Brandon, Florida, United States
Ambros Clinical Trial Site, Daytona Beach, Florida, United States
Ambros Clinical Trial Site, Pembroke Pines, Florida, United States
Ambros Clinical Trial Site, Lawrenceville, Georgia, United States
Ambros Clinical Trial Site, Newnan, Georgia, United States
Ambros Clinical Trial Site, Orland Park, Illinois, United States
Ambros Clinical Trial Site, Overland Park, Kansas, United States
Ambros Clinical Trial Site, Reno, Nevada, United States

Complex Regional Pain Syndrome I (CRPS I)

The goal of this observational study is to learn about how well neridronate keeps working in the months after treatment.…

Multiple LocationsEst. completion Apr 16, 2029

Complex Regional Pain Syndrome Type I (CRPS-I)Distal Radius Fracture

Complex regional pain syndrome type I (CRPS-I) can develop after a distal radius fracture and may cause persistent pain,…

Istanbul, Turkey (Türkiye)Est. completion Jun 26, 2027

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.